Invention Grant
- Patent Title: 4-benzylsulfonyl-2-butenenitrile
-
Application No.: US15245513Application Date: 2016-08-24
-
Publication No.: US09987246B2Publication Date: 2018-06-05
- Inventor: Joseph P. St. Laurent , Gerald S. Jones , David M. Bresse , Scott A. Goodrich
- Applicant: Olatec Therapeutics LLC
- Applicant Address: US NY New York
- Assignee: Olatec Therapeutics LLC
- Current Assignee: Olatec Therapeutics LLC
- Current Assignee Address: US NY New York
- Agency: Perkins Coie LLP
- Agent Viola T. Kung
- Main IPC: A61K31/277
- IPC: A61K31/277 ; C07C317/28 ; A61K31/10 ; A61K9/00
Abstract:
The present invention is directed to a pharmaceutical composition comprising a pharmaceutically acceptable carrier and 4-benzylsulfonyl-2-butenenitrile, or a pharmaceutically acceptable salt or solvate thereof. The present invention is directed to a method for treating inflammation, inflammatory-related disorders, or pain, by administering 4-benzylsulfonyl-2-butenenitrile, or a pharmaceutically acceptable salt or solvate thereof to a subject in need thereof.
Public/Granted literature
- US20160361286A1 4-BENZYLSULFONYL-2-BUTENENITRILE Public/Granted day:2016-12-15
Information query
